HomeTDAC • NASDAQ
Translational Development Acquisitin Crp
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 221.13K | 13,023.26% |
Net income | 1.62M | 96,440.77% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 35.26K | -51.05% |
Total assets | 178.18M | 243,746.91% |
Total liabilities | 184.35M | 31,552.31% |
Total equity | -6.17M | — |
Shares outstanding | 4.66M | — |
Price to book | -7.83 | — |
Return on assets | -0.31% | — |
Return on capital | 9.13% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 1.62M | 96,440.77% |
Cash from operations | -171.35K | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -171.35K | -589.56% |
Free cash flow | -88.42K | — |
Previous close
$10.34
Day range
$10.34 - $10.34
Year range
$10.00 - $10.35
Market cap
226.52M USD
Avg Volume
37.35K
P/E ratio
74.84
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2022
